SEC Filing Update: #IKT Inhibikase Therapeutics, Inc. : $2.41

Sector: Healthcare | YTD: 🔼+ 23.59% The SEC disclosed Today (14-AUG-2026) that PERCEPTIVE ADVISORS LLC has DECREASED #IKT Shares by -18.32% 🔴 NANTAHALA CAPITAL MANAGEMENT, L also reported an increase in its holdings on the same day. * Previous Holdings: 12.64M Shares * Current Holdings: 10.32M Shares * Decrease -2.31M * Decreased (%)-18.32% * Ownership: 6.9% https://www.thinksabio.com/reports/isr/IKT Institutional ownership in #IKT has been steadily rising over the past 9 quarters in Shares: Q1 2024: 205.56K Q2 2024: 836.50K Q3 2024: 860.23K Q4 2024: 50.06M Q1 2025: 51.46M Q2 2025: 54.51M Q3 2025: 54.96M Q4 2025: 106.42M Q1 2026: 115.14M The quarterly average prices of #IKT: Q1 2026: $1.78 📌 Institutional activity in the last 30 days for #IKT: • NANTAHALA CAPITAL MANAGEMENT, L – Increased holdings by 3,108,624 shares (14-AUG-2026) • RA CAPITAL MANAGEMENT – Newly bought 25,000,000 shares (17-JUL-2026) • BLACKROCK INC – Increased holdings by 1,464,571 shares (28-JUL-2026)